Protein Data Bank / Cambridge Isotope Laboratories / C2221 / Oxford University Press / Amundson SA / Marley / Wilson / Creative Commons / GE Healthcare / Crawford SA / Suzuki / Abbott Laboratories / Parma LP / Macmillan Publishers Limited / /
Country
France / United States / Australia / /
Currency
pence / / /
Event
FDA Phase / /
Facility
Castle Hill / N terminal / C terminus / Biotechnology Institute / Bcl-B /
IndustryTerm
initiation site / a1-site / cancer therapeutics / chemical inhibitors / interaction site / cleavage site / space / /
MedicalCondition
acute myelodysplastic syndromes / solid tumours / JE / multiple myeloma / relapsed small cell lung cancer / solid tumors / human cancers / small-cell lung cancer / Puisieux A. Metastasis / lymphoma/leukemia / MS / ovarian and prostate cancers / Cancer / BimS2A32 retroviral infection / Disease / human cancer / lung cancer / diseases / Vaccinia virus / colorectal tumors / /
MedicalTreatment
cancer therapeutics / /
MusicGroup
FC / EF / /
OperatingSystem
Petros / /
Organization
National Health and Medical Research Council of Australia / University of Melbourne / Otago University / CNRS Ecole Normale Supe´rieure de Lyon / Universite´ de Lyon / Leukemia and Lymphoma Society / La Trobe University / Department of Biochemistry / 3Bio21 Molecular Science and Biotechnology Institute / Eliza Hall Institute of Medical Research / Cancer Council Victoria / Oxford University / /
Person
Isar III / / /
Position
Australia *Corresponding author / Porter / /
Product
Nokia N70 Smartphone / Pure F160 Camcorder / Bcl / BH3 / Victoria / Citation / sodium acetate / CL / M-9 / SJ / Navitoclax / BL21 / /
The restricted binding repertoire of Bcl-B leaves Bim as the universal BH3-only prosurvival Bcl-2 protein antagonist